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The crystal structures of the human liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in three different liganding states were determined and compared with
those of the rat testis isozyme. A set of amino acid sequence
heterogeneity from the two distinct genes encoding the two
different tissue isozymes leads to both global and local conformational differences that may cause the differences in
catalytic properties of the two isozymes. The sequence differences in a ␤ⴚhairpin loop in the kinase domain causes a
translational shift of several hydrophobic interactions in
the dimeric contact region, and its propagation to the domains interface results in a 5° twist of the entire bisphosphatase domain relative to the kinase domain. The bisphosphatase domain twist allows the dimeric interactions
between the bisphosphatase domains, which are negligible
in the testis enzyme, and as a result, the conformational
stability of the domain is increased. Sequence polymorphisms also confer small but significant structural dissimilarities in the substrate-binding loops, allowing the differentiated catalytic properties between the two different
tissue-type isozymes. Whereas the polymorphic sequence at
the bisphosphatase-active pocket suggests a more suitable
substrate binding, a similar extent of sequence differences
at the kinase-active pocket confers a different mechanism
of substrates bindings to the kinase-active pocket. It includes the ATP-sensitive unwinding of the switch helix ␣5,
which is a characteristic ATP-dependent conformational
change in the testis form. The sequence-dependent structural difference disallows the liver kinase to follow the
ATP-switch mechanism. Altogether these suggest that the
liver isoform has structural features more appropriate for
an elevated bisphosphatase activity, compared with that of
the testis form. The structural predisposition for bisphosphatase activity in the liver isozyme is consistent with the
liver-unique glucose metabolic pathway, gluconeogenesis.

Due to the two independent catalytic domains in a single
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P2ase),1 catalyzes both the synthesis and degradation of fructose2,6-bisphosphate (Fru-2,6-P2), a most potent allosteric regulator
with dual functions as follows: an activator of phosphofructokinase
and, simultaneously, an inhibitor of fructose-1,6-bisphosphatase,
the key rate-limiting enzymes of glycolysis and gluconeogenesis,
respectively (1–3). The functional duality allows Fru-2,6-P2 to play
a critical role in control of the rates of both glycolysis and gluconeogenesis. An elevated cellular concentration of Fru-2,6-P2 increases
glycolytic flux, whereas a lowered concentration of Fru-2,6-P2 results in a net increase in gluconeogenic flux. Because the liver is the
major organ for vertebrate glucose homeostasis, regulation of the
activity in the liver isoform of 6-Fru(P)-2-kinase/Fru-2,6-P2ase and
the resulting Fru-2,6-P2 regulates glucose homeostasis in an organism (1–5). Reflecting the diversity of tissues and their functions, at
least six different tissue-specific isoforms from five distinct genes
express varying ratios of kinase to bisphosphatase activity. A single
isoform generally predominates in each distinct tissue (1, 4).
The determination of crystal structures of the rat liver Fru2,6-P2ase domain (6) and the rat testis 6-Fru(P)-2-kinase/Fru2,6-P2ase (7) has led a great progress in our understanding of
the catalytic mechanisms of this enzyme system (8, 9). However, one of the most fundamental questions about this enzyme
system has remained unanswered. How are the structures of
the tissue-specific isozymes of 6-Fru(P)-2-kinase/Fru-2,6-P2ase
related to their differential functions in tissues that have specific physiological roles and, accordingly, different optimums of
glucose metabolism? Reflecting such differences in roles, the
two isozymes have been shown to have different kinetic properties, summarized in Table I (adapted from Ref. 10). Despite a
reasonably high amino acid sequence identity (74%), the liver
isoform kinase shows a 4-fold higher affinity for Fru-6-P but
half the Vmax compared with the testis form, whereas the
bisphosphatase has at least 20-fold increased affinity for Fru2,6-P2 and a 2-fold increase in Vmax (10). These kinetic differences suggest that glucose metabolism is uniquely related to
the physiological roles of the given tissues and not just a simple
housekeeping function for energy production (10, 12, 13). This
is more evident by the fact that only the liver isozyme of the two
isozymes is phosphorylated by the cAMP-dependent protein
kinase upon the signal of low levels of glucose and/or glucagon.
The dephosphorylation is achieved by xylulose 5-phosphate
(Xyl-5-P)-dependent protein phosphatase 2A upon the detection of insulin and/or high glucose levels (14 –18). Phosphoryl1
The abbreviations used are: 6-Fru(P)-2-kinase/Fru-2,6-P2ase, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase; Fru-2,6-P2, fructose 2,6bisphosphate; Fru-2,6-P2ase, fructose-2,6-bisphosphatase; Fru-6-P, fructose 6-phosphate; PFK, phosphofructokinase; FBPase, fructose-1,6bisphosphatase; PP2A, protein phosphatase 2A; Xyl-5-P, xylulose
5-phosphate; ATP␥S, adenosine 5⬘-O-(thiotriphosphate); AMP-PNP,
adenosine 5⬘-(␤,␥-imino)triphosphate.
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TABLE I
Comparison of the kinetic parameters of the
isotype bifunctional enzymes
This table is adopted from the original (10), in which the experimental conditions were kept identical to compare the kinetic properties of
the two different tissue-specific isozymes.
Kinetic parameters

6-Fru(P)-2-kinase
Vmax (milliunits/mg)
Km Fru-6-P (M)
Km ATP (M)
Fru-2,6-P2ase
Vmax (milliunits/mg)
Km Fru-2,6-P2 (M)
Ki Fru-6-P (M)

Testis

Liver

90 ⫾ 5
85 ⫾ 5
270 ⫾ 43

57
16
310

22 ⫾ 3,3
21 ⫾ 4.7
3.4 ⫾ 0.2

45
⬎1
3.5

ation of the liver 6-Fru(P)-2-kinase/Fru-2,6-P2ase induces an as
yet unknown conformational change by which the predominant
activity switches from the kinase to the bisphosphatase that
leads to a decrease in the cellular concentration of Fru-2,6-P2
(15, 16) and hence stimulating gluconeogenesis.
Therefore, investigation of the structural differences in tissue isoforms will provide a new insight into the structure/
function relationship, which is differentiated according to the
physiological roles of the tissues expressing those isozymes. To
better understand this unique enzyme system and to provide a
better target for drug design, the crystal structure of the human liver isoform, which has kinetic properties nearly identical
to the rat liver form of better than 98% (as suggested by
sequence identity) (11), was determined and compared with the
rat testis form, and the results are reported here.
EXPERIMENTAL PROCEDURES

Preparation and Crystallization of the Human Liver Bifunctional
Enzyme—The W0 mutant form of human liver 6-Fru(P)-2-kinase/Fru2,6-P2ase (all Trp residues and Pro2 mutated to Phe and Arg, respectively) was employed for this study because it has better expression in
Escherichia coli with the kinetic properties indifferent from those of the
wild type.2 The same mutant form was used for the studies of the testis
form (7). The protein was expressed in E. coli BL21(DE3) and purified
using DEAE and Mono Q anion-exchange chromatography. Crystals
were prepared by hanging drop vapor diffusion at 12 mg ml⫺1 protein
(in 20 mM Tris-HCl, pH 7.25, 10 mM NaPi, 15% glycerol, 0.5 mM EDTA,
10 mM dithiothreitol, 6 mM ATP␥S䡠Mg or ADP, and 5–10 mM Fru-6-P)
mixed 1:1 with a mother liquor of 50 mM Tris-HCl, pH 7.5, 20 –25%
ethylene glycol, and 8% polyethylene glycol 4000. Crystals in a size of
0.2 ⫻ 0.2 ⫻ 0.05 mm were grown in 4 –5 days.
Data Collection and Processing—Crystals were submerged into liquid propane for flash freezing, and the low temperature (120 K) was
maintained by an X-stream (MSC, The Woodlands, TX) cryogenic cooling device. Diffraction data were collected on an R-Axis IV image plate
detector mounted on a Rigaku FR590 rotating anode generator, which
was operated at 50 mA, 100 kV. The x-ray beam was focused using an
Osmic confocal multilayer optic system. The data were integrated using
DENZO and merged and scaled with SCALEPACK (20). The reduced
data were formatted for the CCP4 suite (21), and 10% of the data were
marked for free R-factor measurements in subsequent structure refinements. As shown in Table II, complete data sets with various resolution
ranges depending on the liganding states were collected. All crystals
belong to a C2 space group regardless of the bound ligands. The data
statistics are summarized in Table II.
Structure Determination and Refinement—The structure of the
ATP␥S complex was determined first by the molecular replacement
method using X-PLOR (22). A single polyalanine form of the testis
structure (Protein Data Bank accession code 1bif) was used as a search
model. An X-PLOR rotation and subsequent translation search was
performed using a data subset between 15.0 and 4.0 Å. A self-rotation
search as well as the measurement of solvent fraction suggested a
non-crystallographic dimer of the liver enzyme in 1 asymmetric unit.
Assignment of the side chains and non-crystallographic dimerization
was made using O (23). The initial model went through iterated cycles
2

K. Uyeda, unpublished data.

of manual model rebuilding and X-PLOR refinement, followed by two
cycles of “refmac” refinement (21). During this procedure, a single
model was the subject of all manual model corrections to prevent the
accumulation of structural errors developed during the refinement cycles. When Rcrys/Rfree, reached 0.254/0.289, one molecule of ATP␥S per
protein molecule was built into the model, referring to an Fo ⫺ Fc omit
map. As shown in Table II, the final model has a Rcrys/Rfree factor of
0.217/0.257 using a total of 7,545 scatterers, including solvent molecules, against 42,142 reflections. Of the 864 residues in the dimer,
89.3% are within the “most favorable region” of main chain dihedral
angles distributions and none in the “disallowed region,” when judged
using “procheck” (21). The final structure was deposited in the Protein
Data Bank under the accession code of 1K6M.
The subsequent structures of the liver isozyme complexed with either
ADP or Pi were determined by using the structure of the ATP␥S complex as the starting model and by following the structural refinements
procedures similar to that used for the ATP␥S complex. But, to guarantee a freedom to structural refinements, the indices of reflections in
the free data were kept as those of the ATP␥S complex. The B-factor
refinement of the Pi complex was stopped after one cycle of group
B-factor refinement, and the solvent molecules were not added to the
structure due to a limited resolution. The statistics of reflection data
and structure refinements are summarized in Table II.
RESULTS AND DISCUSSION

Similarity of Overall Folding in the Liver and Testis Isoforms—The crystal structures of the liver isozyme reveal a
head-to-head homodimer of 432 amino acid residues per monomer (residues 39 – 470) (Fig. 1a and 2). Depending on the
liganding conditions, each subunit contains an ATP␥S, ADP, or
Pi molecule bound to the kinase domain, and two inorganic
phosphates, regardless of the liganding conditions, bound to
the bisphosphatase domain (Table II). No electron density is
interpretable for the N-terminal regulatory fragment of residues 1–38, in which Ser-32, the cAMP-dependent phosphorylation site (24 –27), and a number of amino acid sequence differences are located (Fig. 2). The structure of this fragment
thus remained undetermined in both the liver and testis
isozymes.
As predicted from a reasonably high sequence identity (74%)
of tissue isozymes (Fig. 2), the liver bifunctional enzyme has a
structure very similar to that of the testis isoform, consistent
with similarities in their catalytic mechanisms (7, 9 –11, 28). As
shown in Fig. 1b, where the ribbon diagrams of the two isozyme
kinase domains are superimposed, the overall folding of the
liver form is very similar to that of the testis form. The similarity in folding patterns is maintained throughout both the
kinase and phosphatase domains. The main structural characteristics are conserved in the liver form, i.e. the major dimeric
interactions through the kinase domains, the constellation of
catalytic residues in the active sites of each domain, and the
manner of intramonomer domain-domain interactions.
All this together allowed us to assign the secondary structural motifs of the liver form according to those of the testis
form (7) with no ambiguity, and for convenience of comparison,
the amino acid sequences are compared with the assigned
secondary structures in Fig. 2. Unless specifically mentioned,
for the entire text of this report, all the amino acid sequence
and numbers are according to the liver isozyme. For example,
T224Q is Thr-224 in human liver 6-phosphofructo-2-kinase/
fructose-2,6-bisphosphatase and is Gln in the same position of
the testis isozyme.
Bisphosphatase Twist and Differentiated Dimeric Interface—
Although the number is small, the amino acid sequence differences between the two tissue isozymes seem to cause a variety
of conformational differences. That includes a twist of the
bisphosphatase domain relative to the kinase domain, resulting in an altered dimeric interface. Despite the fact that the
amino acid residues involved in this interface are relatively
well conserved, the bisphosphatase domain of the liver form is
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TABLE II
Statistics of reflection data and structure refinements
Numbers in parentheses are values in the highest resolution shell. Rsym ⫽ ⌺h(⌺j兩Ih, j ⫺ ⬍Ih⬎兩/⌺Ih, j), where h ⫽ set of Miller indices and j ⫽ set
of observations of reflection h. R.m.s.d. values are deviation from ideal values.
Kinase-bound ligands

ATP␥S

ADP

Pi

Unit cell dimension (Å)
␤-Angle (°)
Resolution range (Å)
No. reflections
[Fⱖ(F)]
Completeness (%)
Redundancy
I/(I)
Rsym
Rcrys
Rfree
No. amino acids
No. protein atoms
No. hetero-atoms
No. waters
R.m.s.d. bond lengths (Å)
Angles (°)
Dihedral angles (°)
Mean B-factor
Protein atoms (Å2)
Hetero atoms (Å2)
Water atoms (Å2)

74.98 ⫻ 185.33 ⫻ 89.67
90.74
30.0–2.4

74.90 ⫻ 183.24 ⫻ 89.93
91.06
30.0–2.6

74.66 ⫻ 183.63 ⫻ 91.18
90.60
30.0–3.0

FIG. 1. Stereo views of dimeric arrangement of the liver form and a
comparison of the structures of the
two isoforms. a, dimeric arrangement of
the functional liver isozyme subunits
about the crystallographic 2-fold axis of
rotation is shown as a C␣ trace. Each
monomer is colored differently, and the
residue numbers are labeled every 25 residues. b, the monomeric structures of each
isozyme were superimposed by a least
square fit of the testis kinase domain onto
that of the liver form using O (23). The
liver kinase and bisphosphatase domains
are colored red and blue, respectively, and
those of the testis form are both in gray.
Note that the liver Fru-2,6-P2ase domain
is rotated ⬃5° relative to the same domain of the testis form. The secondary
structure motifs involved in dimeric contacts are labeled (␤1–5, ␤1– 6, and ␣7).
The positions of amino sequence differences related to different dimeric interactions and the bisphosphatase twist are
shown as the dark dots. All the structural
figures were produced and rendered using
Molscript (33) and Raster3D (19).

42,142
95.5 (94.4)
3.9 (3.6)
20.1 (2.0)
0.074
0.217
0.257
864
7054
94
397
0.011
1.9
29.6
34.7
41.6
49.9

36,675
98.8 (92.3)
3.4 (2.9)
21.3 (1.9)
0.080
0.214
0.262
864
7054
74
279
0.012
2.0
29.5
32.9
43.5
48.6

21,677
96.7 (87.2)
2.8 (2.2)
11.1 (1.7)
0.093
0.253
0.289
864
7054
30
0.008
1.7
29.3
35.1
39.8
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FIG. 2. Comparison of the amino acid sequences of the liver and testis isozymes. Identity of the sequences was compared along with their
secondary structures. The identical sequences are represented by ⫺ and deletions or insertions by a period.

twisted by 5° around the dimeric axis from its position in the
testis form (Fig. 1b). We considered three possibilities of this
twist as follows: an indirect effect of the mobile N terminus, a
difference in crystal contacts between the two isoforms, and an
intrinsic difference coming from the amino acid sequence. A
possibility of an effect of phosphorylation of Ser-32 at the
mobile N terminus is ignorable since the enzyme was expressed
in bacterium and purified in the absence of any protein phosphatase inhibitor such as fluoride. To test its relevance to
liganding states and crystal contacts, the three structures of
the testis isoform all in different crystal contacts and liganding
states (ATP␥S, AMP-PNP, and Pi) (7, 9, 28) and the three
structures of the liver form in three different liganding states
(ATP␥S, ADP, and Pi) were cross-compared by superimposing
onto each other. The positional differences of C␣s were calculated and presented as Table III. The liver form ADP complex
and the testis form AMPPNP complex were excluded from this
table, because they were so similar to the liver form ATP␥S
complex and the testis form ATP␥S complex, respectively, with
a difference range of ⬍0.5 Å. It is evident that the overall
difference (⬃2 Å) between the two tissue isozymes is mainly
caused by the bisphosphatase domain (⬃3 Å). This difference is
not significantly affected by the liganding states, which cause
less than 1 Å in magnitude. Legitimacy of the positional difference was tested by rotating the testis bisphosphatase domain
by 5°, and the result, which is 2.8 Å, was found to be close to the
value in the table. Because no different space group with reasonable resolution is available for the liver form, it is impossible to directly infer the effect of crystal contacts on the liver
form. However, comparisons between the structures of the
testis form, which have three different space groups (P1 for the
Pi complex, C2 for the AMPPNP complex, and P3121 for the
ATP␥S complex), allowed an indirect observation. When these
three structures were compared, the positional differences
caused by the different crystal contacts are neither domainspecific nor significant (⬍0.8 Å). This observation becomes
more convincing by the fact that the major source of crystal
contacts in both isoforms is provided by the conserved dimeric
kinase interactions. All this together suggests that the rotated
bisphosphatase is a featuring conformation of the liver form.
Moreover, it was found that the amino acid sequence differences in the kinase domain can cause a twist of the liver form

TABLE III
Average positional differences of C␣ among the isotype bifunctional
enzymes and their domains (Å)
The positional differences of the C␣ atoms of the two isozymes each in
two different liganding conditions (ATP and Pi) are compared after
superimposing the structures onto each other. The numbers in parentheses are representing the kinase and bisphosphatase domains, respectively. The space groups of the crystals are also in parentheses. The
structures of testis䡠Pi and Testis䡠ATP␥S were acquired under the PDB
codes, 1bif and 3bif, respectively.

Testis䡠Pi
(P1)
Testis䡠ATP␥S
(P3121)
Liver䡠Pi

Liver䡠ATP␥S
(C2)

Liver䡠Pi
(C2)

Testis䡠ATP␥S

2.28
(1.05/3.45)
1.86
(0.86/2.82)
0.34
(0.22/0.45)

2.25
(1.07/3.38)
1.83
(0.87/2.75)

0.69
(0.63/0.76)

bisphosphatase domain. As in the testis form, the kinase/
bisphosphatase interface of the liver enzyme includes a structure in which one ␤ hairpin between ␤1–5 and ␤1– 6 (residues
215–230 in the liver form and 213–228 in the testis form) in the
kinase domain forms a set of hydrophobic interactions with the
following helix ␣7 in the kinase domain, which in turn makes
tight interactions with the bisphosphatase helix ␣13 (7). A
major portion of this junction also serves as the dimeric interface through intermonomeric kinase domain interactions (Fig.
3a). Sequence heterogeneity introduced at the three residues,
T224Q, R225S, and Q232A, of this hairpin may have caused the
bisphosphatase domain twist and, also, affected the dimeric
interactions. As shown in Fig. 3a, the hairpin loop in the liver
type forms a new intermolecular salt bridge with Glu-208 of the
dimeric partner molecule, because of a newly introduced positive charge in Arg-225, and this tends to pull the loop upward.
This upward movement is strengthened by T224Q, which forms
a new hydrogen bond with the carbonyl O of Asp-221 in the
same subunit, losing the intersubunit hydrogen bonding with
Arg-230. Q232A also helps this structural change by introducing a new hydrogen bond to Ser-215. As a result, the hairpin
structure is rotated by ⬃3° and shifted by 0.4 – 0.6 Å with
respect to that of the testis form. To adjust for this structural
change and to maintain tight hydrophobic interactions with the
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FIG. 3. Stereo views of junction of
the kinase and bisphosphatase domains. a, differences in the ␤1–5 and -6
hairpin viewed from the dimeric interface. The three residues, T224Q, R225S,
and Q232A, which cause the bisphosphatase twist are shown. The two liver
kinase domains are represented by different colors (magenta and blue), and those
of rat testis 6-phosphofructo-2-kinase/
fructose-2,6-bisphosphatase are shown in
light gray. The dimeric interactions in the
liver form are shown with the dark dotted
lines, and the related interactions in the
testis form are colored light gray. The
2-fold rotation axis is represented by a ⽧.
Note that the dimeric interaction pattern
in the liver form causes an upward and
rotational shift of the ␤1–5/␤1– 6 hairpin
loop. b, the side chains of the residues
involved in the kinase/bisphosphatase domain interface are shown demonstrating
the positional differences between the
liver and testis isozymes. The liver kinase
and bisphosphatase domains are colored
red and blue, respectively, while light
gray is used for the testis form. Glu-208
from the magenta loop is from the dimeric
partner kinase subunit. Note that the positional differences of the residues and
the secondary structure motifs involved
in this interdomain junction gradually increase from the top to the bottom.

TABLE IV
Comparison of the dimeric parameters
The buried surface areas were calculated using “areaimol” (30).
Buried surface areas caused by interactions (Å2)
Source of interactions

Dimeric
Monomeric
Dimeric
Dimeric
Dimeric

Subunit/subunit
Kinase/bisphosphatase
Kinase/kinase
Bisphosphatase/bisphosphatase
Kinase/bisphosphatase

Liver

Testis

⌬ area

2490
1700
1394
763
333

1787
1768
1259
164
364

703
⫺68
135
599
⫺31

Liver

Testis

⌬ distance

3.2
2.9
3.9
2.9
2.5
3.0
3.7
2.5
2.8

3.7
3.0
5.4
4.0
2.8
2.7
3.9
2.8
7.3

⫺0.5
0.1
⫺1.5
⫺1.1
⫺0.3
0.3
⫺0.2
⫺0.3
⫺4.5

Distances of dimeric interactions (Å) involving the bisphosphatase domains
Source atoms involved

Asp-233-O
His-234-N␦1
His-234-O
Ser-237-O␥
Arg-238-N1
Lys-323-N
Tyr-241 (hydrophobic)
Tyr-241-O
Glu-335-O1

Arg-383-N1
Glu-380-O1
Arg-383-N2
Asn-245-N␦2
Tyr-241-O
Asp-369-O␦2
Tyr-241
Arg-238-N1
Lys-363-N
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hairpin, the helix ␣7 has made a translational shift (Fig. 3b),
which is helped by a new hydrogen bond between Q232A and
Ser-215 (Fig. 3a). The shift of ␣7 induces a similar type of
movement in ␣13. In this way, a small shift of the ␤-hairpin is

FIG. 4. Distribution of the temperature (B-) factors in the two
isozymes. The C␣ atom B-factors of the structures of the two isoforms
in the same liganding state are compared with each other. The B-factors
are expressed as standard deviations from the average values of each
structure: dark line, the liver form; gray, the testis form. The functional
roles of the protein motifs are labeled above the plots. The motifs used
as crystal contacts are underlined as follows: solid line, the liver form;
dotted line, the testis form.

FIG. 5. Sequence-related differences in the substrate loops of the
kinase domain. a, ATP-induced switch
motion in the liver isozyme. The ␣5 helix
of the liver form (blue) is compared with
that of the testis form (gray). The dotted
lines demonstrate the additional sequence-related interactions unique in the
liver isoform stabilizing the ATP switch:
dark dots, hydrogen bonds; green dots, hydrophobic interactions. b, conformation of
the ␣5 helix upon bindings of ADP or Pi.
Note that Lys-174 of testis form (gray)
swings out from the bound Pi, and the
same result is shown in the ADP complex
(data not shown). c, lost coupling between
the substrate loops in the liver kinase domain. The sequence difference at C183R
causes a loss of hydrogen bonds in the
liver form, which serve to couple the two
substrate loops in the testis form. The
ATP and Fru-6-P loops of the liver enzyme are colored magenta and blue, respectively, whereas the testis loops are in
gray. The hydrogen bonds in the testis
isozyme are shown with dark dotted lines.

propagated to the rest of the structural components of the
junction between the kinase and bisphosphatase domains,
eventually causing a 5° swing of the bisphosphatase domain
(Fig. 1b).
Intramolecular rotation of the bisphosphatase domain appears
to enhance the overall stability of the bisphosphatase domains in
the liver form by introducing new dimeric interactions between
the Fru-2,6-P2ase domains. As summarized in Table IV, the
conformation distinguishes the liver isozyme from the testis
form, causes a 4-fold increase in the buried surface area between
the two bisphosphatase domains, and decreases the distances in
the dimeric kinase/bisphosphatase interaction as well. Interestingly, neither the increased contact areas nor the decreased distances between the two bisphosphatase domains are caused by
amino acid sequence differences within the bisphosphatase domain. The polymorphic sequences in the kinase domain that
induce the twist between the kinase and bisphosphatase domains
are the sole cause of increases in the dimeric interactions between the bisphosphatase domains.
When deviations from mean B-factors of the testis ATP␥S
complex and the liver ATP␥S complex are plotted, significant
differences in the stability of the 6-Fru(P)-2-kinase (residues
39 –249) and Fru-2,6-P2ase (residues 250 – 470) domains of the
two isozymes are revealed (Fig. 4). A very similar pattern was
also shown in other structures (data not shown for clear com-
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FIG. 6. The substrate loops in the
liver bisphosphatase domain. The sequence difference-related new interactions that stabilize the loops surrounding
the 2-P motif and the 6-P motif of Fru2,6-P2 are shown using dark dotted lines.
Different colors of the ribbon diagram
represent different subunits: magenta,
the first subunit of the liver form; green,
the other subunit in dimeric contact; and
gray, rat testis 6-phosphofructo-2-kinase/
fructose-2,6-bisphosphatase. Note that
the sequence difference at E347L causes a
change in the arrangement of a local hydrophobic patch and that the interaction
between Glu-335 and Lys-363 is introduced by the bisphosphatase twist in the
liver isoform.

parisons). This comparison dramatically shows that the Fru2,6-P2ase domain of the liver isozyme is the more stable half of
the monomer liver isozyme. Conversely, the 6-Fru(P)-2-kinase
domain of the testis isozyme is the more stable domain. This
distinct domain stability is not an artifact of different crystal
contacts between the two isoforms. As shown on the bottom of
the plot, most of the crystal contacts are shared, and the several unique contacts do not explain the unique stability of the
tissue-specific isoforms. This difference was apparent throughout the structure refinement process, where the liver bisphosphatase domain always had an overall more interpretable density map than the kinase domain, opposite the situation seen in
the testis structures. The liver bisphosphatase domain is more
stable than its own kinase domain and the testis bisphosphatase domain. On the contrary, the testis kinase domain is
more stable than its bisphosphatase domain and the liver kinase domain. However, it is unclear whether the increase in
the buried surface area by the twisted bisphosphatase causes
the liver bisphosphatase domain to be more stable.
Differentiated Substrate-binding Loops in the Kinase Domain—Outside of the N-terminal regulatory motif (residues
1–38), polymorphic amino acid sequences between the liver and
testis isozymes are most frequent in the substrate binding
loops of the kinase domain: the Fru-6-P loop (residues 80 –120)
and the ATP loop (residues 160 –200) (Fig. 2). In the testis
isozyme, it was shown that the last turn of helix ␣5 (residues
162–175) undergoes unwinding upon binding of ATP to recruit
Lys-172 to the bridge oxygen between the ␤- and ␥-phosphates
of the bound ATP (9, 29). This ATP-driven conformational
change has been suggested to be transmitted to the Fru-6-P
loop via the loop coupling composed of the salt bridges between
Asp-177, Arg-78, and Arg-193 and the hydrogen bonds between
Arg-181 and the carbonyl oxygens of Tyr-85 and Lys-86 (9, 29).
Thus, the ATP binding was suggested to be a prerequisite for
the subsequent binding of Fru-6-P to the kinase domain in the
testis kinase reaction, following the ordered binding of
substrates.
Like the testis form and as shown in Fig. 5a, the structure of
the liver form also has a “switch-on” conformation induced by
the bound ATP. Neither of the two additional structures of the
liver enzyme complexed with ADP or Pi shows the “switch-off”
conformation, which is shown by the testis enzyme upon bindings of ADP or Pi (Fig. 5b). Furthermore, substitution of cysteine for Arg-183 in the liver isozyme (C183R) breaks the outer
lobe coupling of the ATP and Fru-6-P loops (Fig. 5c). It is

believed that the sequence differences in this region stabilize
the “switch-on” conformation of the liver enzyme. Mutation in
G164E appears to greatly enhance the hydrophobic interactions between I165V and Val-222 by introducing more flexibility into the first turn of the switch helix (␣5), and as a result,
the distance between Ile-165 and Val-222 is shortened to 3.8 Å
from 4.9 Å. In addition, a different sequence at E168A introduces a new hydrogen bond to the main chain N of Gln-172.
Furthermore, the residue differences of V188A, L189T, and
L193M add new sources of interactions to a local hydrophobic
pocket made of Tyr-180, Leu-175, Phe-192, and Ile-170 (Fig.
5a), which has been shown to be important in the binding of
ATP and Fru-6-P (9).
These sequence-related structural differences altogether appear to stabilize the switch-on conformation of the liver isoform
by locking down the switch-on conformation and to isolate the
Fru-6-P loop from the conformational changes in the ATP loop.
To have the “off ” (ATP-free) conformation suggested in the
testis enzyme, the new hydrophobic interactions introduced by
V188A, L189T, and L193M have to be broken. Thus, it appears
that the helix (␣5) of the liver form would experience a much
higher energy barrier than that of the testis isoform when it
returns to the ATP-free conformation. Because of the additional hydrogen bond through the side chain of E168A and the
strengthened local hydrophobic interactions, it is likely that
the ATP-induced switch-on conformation of the liver form is
more stable than that of the testis form. The two substrate
loops are mutually independent from the conformations of the
other, resulting in an enhanced affinity for Fru-6-P. This observation allows the conclusion that the substrate binding to
the liver kinase follows a random fashion, as originally suggested by the previous kinetic studies of the liver form (30), and
that stabilized ATP-induced switch-on conformation together
with the decoupled substrate loops may contribute to a 4-fold
higher affinity of the liver kinase for Fru-6-P (1, 10).
Differentiation in the Bisphosphatase Domain—As mentioned earlier, a prominent feature of the liver isozyme is the
increased stability of the bisphosphatase domain induced by
the bisphosphatase twist and the concomitant increase in dimeric interactions between the bisphosphatase domains (Table
IV). In addition, polymorphic amino acid residues apparently
contribute to an enhanced stability of loops involved in substrate binding to the bisphosphatase domain. The sequence
change at R266K introduces a new salt bridge between Arg-266
and Glu-262. In addition, a change at S273P stabilizes the loop
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(residues 260 –280), which surrounds the 2-P position of the
bisphosphatase-active site, by forming a new hydrogen bond
with the main chain N of Leu-263 (Fig. 6).
The amino acid difference at residue E347L pushes Glu-347
away from the hydrophobic pocket consisting of E347L, Leu351, and Ile-455 and includes Tyr-359 instead (Fig. 6). The
rearranged hydrophobic pocket shifts the loop 358 –361 such
that a salt bridge between Arg-360 and Asp-369 becomes more
stable. The distance of this salt bridge is shortened from 3.5 to
2.7 Å, and as a result, the B-factors of Arg-360 and Asp-369
decrease by ⬃27 and 7 Å2, respectively, from those of the testis
form. In addition, a new salt bridge between Glu-335 and
Lys-363 is formed by the enhanced dimeric bisphosphatase
interactions, and as a result, the B-factors are decreased by 15
and 19 Å2 from those of the testis form. This conformational
change makes the loop (residues 335–363) more stable, which
serves as a lid of the active site of the bisphosphatase domain
(6, 7) and harbors a number of residues interacting with the
6-phosphate moiety of substrate and product (31, 32). This loop
has served as a popular target of the earlier structure/function
studies and has been shown to be critical in the proper binding
of both Fru-6-P and Fru-2,6-P2. The site-directed mutants,
Arg-352 3 Ala, Lys-356 3 Ala, and Arg-360 3 Ala, showed
more than 100-fold decreases in binding of both Fru-6-P and
Fru-2,6-P2. Thus, in addition to the domain stabilization by the
twist, it is likely that stabilization of both the 2-P and the 6-P
loop structures by the amino acid sequence of the liver isozyme
plays an important role in the 20-fold increase in its affinity for
Fru-2,6-P2 compared with that of the testis form, reflecting the
differences in their kinetic and allosteric properties, consistent
with their different physiological roles (1–3, 11–13).
Physiological Significance—Sequence differences between
the human liver and rat testis isozymes result in both local and
global differences in the structures of these isozymes. The local
conformational differences in the liver form kinase domain
result in a loose coupling (or decoupling) of the Fru-6-P- and
ATP-binding loops and a stabilized switch-on conformation
even without ATP. These structural differences may allow the
Fru-6-P binding to be independent of ATP binding unlike the
testis form, in which ATP-binding is prerequisite for Fru-6-P
binding. This structure-related functional difference may be
related to the physiological roles of the tissues that harbor
these isozymes. To regulate the blood glucose levels, the liver
appears to harbor an isozyme that is more sensitive to the
changes in Fru-6-P concentration, which is a more accurate
indicator of glucose concentration than that of ATP. Meanwhile, the testis isozyme, which functions to maintain a steady
level of energy production, appears to adopt a structure more
sensitive to the changes in ATP concentration, a more accurate
indicator of the cellular energy level than Fru-6-P. Stabilization of the whole bisphosphatase domain by the “domain twist”
and its Fru-2,6-P2-binding loops by the local sequence differ-

ences in the liver isozyme appears to enhance its affinity for
Fru-2,6-P2. Considering that the Fru-2,6-P2 concentration is a
critical factor in determining the flux through the glucose pathways in liver, it is reasonable that the liver bisphosphatase
domain has a keen sensitivity to the concentration of Fru2,6-P2 to actively engage in such a mission. However, by having
lower affinity for Fru-2,6-P2, the testis isozyme is likely to have
the bisphosphatase domain functioning not to determine direction of the pathways but to regulate only the rate of glycolysis.
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